RADNOR, Pa., June 17, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a…
NEW YORK, June 16, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ChemoCentryx, Inc. ("ChemoCentryx"…
LOS ANGELES, June 11, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming July 6,…
RADNOR, Pa., June 11, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds ChemoCentryx, Inc.…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
NEW YORK, June 11, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NOVN, CMMB, PGEN, CCXI, and SENS. To…
NEW YORK, June 11, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ChemoCentryx, Inc. ("ChemoCentryx"…
SAN FRANCISCO, June 10, 2021 /PRNewswire/ -- Hagens Berman urges ChemoCentryx, Inc. (NASDAQ: CCXI) investors with significant losses to submit…
-- Abstract on The Effect of Avacopan, a Complement C5a Receptor Inhibitor, on Kidney Function in Patients with ANCA-Associated Vasculitis…
RADNOR, Pa., June 5, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP alerts investors that…
When everything is riding on a single outcome, speed bumps can send a stock careening....…
NEW YORK, June 1, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ChemoCentryx, Inc. ("ChemoCentryx"…
RADNOR, Pa., May 30, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a…
SAN DIEGO, May 27, 2021 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP, is investigating potential claims against ChemoCentryx,…
BENSALEM, Pa., May 25, 2021 /PRNewswire/ -- Law Offices of Howard G. Smith reminds investors of the upcoming July 6,…
Tyree, James L. - Aufsichtsrat - Tag der Transaktion: 2021-05-21...…
8-K...…
RADNOR, Pa., May 24, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP alerts investors that…
Investors need to pay close attention to ChemoCentryx (CCXI) stock based on the movements in the options market lately....…
NEW YORK, May 19, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of…
RADNOR, Pa., May 18, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds ChemoCentryx, Inc.…
NEW YORK, May 18, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ChemoCentryx, Inc. ("ChemoCentryx"…
RADNOR, Pa., May 12, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that…
LOS ANGELES, May 11, 2021 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of…
NEW YORK, May 11, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ChemoCentryx, Inc. ("ChemoCentryx"…
Butt, Tausif - Vorstand - Tag der Transaktion: 2021-05-07...…
NEW YORK, May 10, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…
Toward the end of trading Friday, the Dow traded up 0.62% to 34,761.24 while the NASDAQ rose 0.95% to 13,762.12.…
8-K...…
Investors arent optimistic after an FDA advisory committee vote for avacopan....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
ChemoCentryx (NASDAQ: CCXI) shares are trading lower following a vote from the FDA panel on whether the efficacy data support approval…
Shares of ChemoCentryx Inc. tumbled 61.7% in trading on Friday, the day after a Food and Drug Administration advisory…
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.
THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING…
ALLE STRUKTURIERTEN PRODUKTE MIT UNDERLYING US16383L1061 SIND AB 15:40 CET WIEDER IN DEN HANDEL AUFGENOMMEN.
ALL STRUCTURED PRODUCTS WITH UNDERLYING US16383L1061…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME …
ALLE STRUKTURIERTEN PRODUKTE MIT UNDERLYING US16383L1061 SIND AB SOFORT VOM HANDEL AUSGESETZT BIS AUF WEITERES.
ALL STRUCTURED PRODUCTS WITH UNDERLYING US16383L1061…
Instrument ID [8439] (2CX - US16383L1061) suspended...…
SAN CARLOS, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced the outcome of…
NEW YORK, May 6, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities…
NEW YORK, May 5, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ChemoCentryx, Inc. ("ChemoCentryx"…
MILWAUKEE, May 5, 2021 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against ChemoCentryx (NASDAQ: CCXI). The investigation…
The FDAs briefing documents for an advisory committee dont appear to bode well for avacopans chances of approval....…
Cocrystal Pharma, Inc. (NASDAQ: COCP), ChemoCentryx, Inc. (NASDAQ: CCXI), Neuronetics, Inc.
read more...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
2021Q1 10-Q...…
